Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma
Clinical trial NCT00101127 · COMPLETED
Trial details
- NCT number
- NCT00101127
- Sponsor
- Gynecologic Oncology Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-12-01
- Primary completion
- 2006-07-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.